Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2009

Conditions
Irritable Bowel Syndrome (IBS)
Interventions
DRUG

SMS995

DRUG

Placebo

Trial Locations (7)

55905

Novartis Investigator Site, Rochester

02215

Novartis Investigator Site, Boston

Unknown

Novartis Investigator Site, Hamilton

Novartis Investigator Site, Gothenburg

Novartis Investigator Site, London

Novartis Investigator Site, Manchester

Novartis Investigator Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY